RAB11FIP1

gene
On this page

Also known as RCPFLJ22622FLJ22524Rab11-FIP1

Summary

RAB11FIP1 (RAB11 family interacting protein 1, HGNC:30265) is a protein-coding gene on chromosome 8p11.23, encoding Rab11 family-interacting protein 1 (Q6WKZ4). A Rab11 effector protein involved in the endosomal recycling process.

This gene encodes one of the Rab11-family interacting proteins (Rab11-FIPs), which play a role in the Rab-11 mediated recycling of vesicles. The encoded protein may be involved in endocytic sorting, trafficking of proteins including integrin subunits and epidermal growth factor receptor (EGFR), and transport between the recycling endosome and the trans-Golgi network. Alternative splicing results in multiple transcript variants. A pseudogene is described on the X chromosome.

Source: NCBI Gene 80223 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 214 total
  • MANE Select transcript: NM_001002814

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30265
Approved symbolRAB11FIP1
NameRAB11 family interacting protein 1
Location8p11.23
Locus typegene with protein product
StatusApproved
AliasesRCP, FLJ22622, FLJ22524, Rab11-FIP1
Ensembl geneENSG00000156675
Ensembl biotypeprotein_coding
OMIM608737
Entrez80223

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 7 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000287263, ENST00000330843, ENST00000522727, ENST00000522774, ENST00000523182, ENST00000524118, ENST00000882279, ENST00000966921, ENST00000966922

RefSeq mRNA: 2 — MANE Select: NM_001002814 NM_001002814, NM_025151

CCDS: CCDS34881, CCDS34882

Canonical transcript exons

ENST00000330843 — 6 exons

ExonStartEnd
ENSE000012362753787451537875322
ENSE000013123343787127837873179
ENSE000021049553789907137899497
ENSE000021122143785861837863113
ENSE000034996993787042037870528
ENSE000036367783787710937877551

Expression profiles

Bgee: expression breadth ubiquitous, 273 present calls, max score 99.28.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 23.6572 / max 1145.3604, expressed in 1510 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
9271823.65721510

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
esophagus squamous epitheliumUBERON:000692099.28gold quality
lower lobe of lungUBERON:000894997.91gold quality
epithelium of esophagusUBERON:000197697.87gold quality
amniotic fluidUBERON:000017396.94gold quality
bronchial epithelial cellCL:000232896.73gold quality
oral cavityUBERON:000016796.50gold quality
islet of LangerhansUBERON:000000696.49gold quality
squamous epitheliumUBERON:000691496.29gold quality
jejunal mucosaUBERON:000039995.89gold quality
ileal mucosaUBERON:000033195.79gold quality
colonic mucosaUBERON:000031795.74gold quality
tongue squamous epitheliumUBERON:000691995.60gold quality
mucosa of sigmoid colonUBERON:000499395.55gold quality
nasal cavity epitheliumUBERON:000538495.30gold quality
epithelium of nasopharynxUBERON:000195195.28gold quality
pharyngeal mucosaUBERON:000035595.13gold quality
epithelium of bronchusUBERON:000203195.07gold quality
bronchusUBERON:000218594.97gold quality
rectumUBERON:000105294.07gold quality
cervix squamous epitheliumUBERON:000692293.97gold quality
upper leg skinUBERON:000426293.96gold quality
duodenumUBERON:000211493.92gold quality
bloodUBERON:000017893.20gold quality
palpebral conjunctivaUBERON:000181293.04gold quality
deciduaUBERON:000245093.03gold quality
bone marrowUBERON:000237192.91gold quality
mucosa of paranasal sinusUBERON:000503092.40gold quality
monocyteCL:000057692.27gold quality
tracheaUBERON:000312692.26gold quality
lungUBERON:000204892.24gold quality

Single-cell (SCXA)

Detected in 11 experiment(s), a significant marker in 10.

ExperimentMarker?Max mean expression
E-CURD-114yes54.32
E-HCAD-6yes44.85
E-MTAB-10287yes40.98
E-MTAB-9467yes22.37
E-CURD-122yes12.84
E-GEOD-135922yes10.40
E-GEOD-130148yes9.56
E-CURD-46yes9.46
E-MTAB-6678yes7.72
E-CURD-89no335.80
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

223 targeting RAB11FIP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-3925-3P100.0069.951237
HSA-MIR-5692A100.0074.406850
HSA-MIR-8485100.0077.574731
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-196A-1-3P99.9972.152772
HSA-MIR-118499.9968.191458
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-569699.9872.364487
HSA-MIR-548AN99.9770.912817
HSA-MIR-302C-5P99.9772.563642
HSA-MIR-314899.9775.066478
HSA-MIR-302E99.9670.742669
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-128-3P99.9571.172484
HSA-MIR-216A-3P99.9571.192505
HSA-MIR-144-3P99.9473.982698
HSA-MIR-101-3P99.9475.032230

Literature-anchored findings (GeneRIF, showing 36)

  • Rab coupling protein (RCP), a novel Rab4 and Rab11 effector protein (PMID:11786538)
  • Receptor cell surface expression and endocytosis experiments reveal that the small GTPase Rab11 protein is a determinant factor in controlling thromboxane A2 receptor beta isoform recycling back to the cell surface. (PMID:15134434)
  • RCP functions primarily as a Rab11 binding protein that regulates protein sorting in tubular endosomes. (PMID:15181150)
  • Rab11, rather than Rab4, mediates the intracellular localisation of RCP. (PMID:15280022)
  • Acting as an intermediate between Rab4 and Rab11, RCP regulates membrane flux along the phagocytic pathway via recycling events. (PMID:15355514)
  • once the Rab11/RCP-regulated cargo has been delivered from the endocytic recycling compartment to the plasma membrane, RCP is inactivated by calpain-mediated proteolysis (PMID:15769254)
  • Rab11 and microtubules maintain the proper distribution of the subapical AQP2 storage compartment, and actin filaments regulate the trafficking of AQP2 from early endosomes to the storage compartment. (PMID:16049696)
  • Results describe the endometrial expression of Rab coupling protein and its hormonal regulation. (PMID:16216915)
  • identified eight alternatively spliced Rab11-FIP1 gene transcripts from human chromosome 8 (PMID:16920206)
  • RCP provides a scaffold that promotes the physical association and coordinate trafficking of alpha5beta1 and EGFR1 and that this drives migration of tumor cells into three-dimensional matrices. (PMID:18838556)
  • RCP is a human breast cancer-promoting gene with Ras-activating function. (PMID:19620787)
  • FIP1/RCP binding to Golgin-97 is required for tethering and fusion of recycling endosome-derived retrograde transport vesicles to the trans-Golgi network. (PMID:20610657)
  • An interaction with Rab11 is necessary for long-range targeting of beta1 integrins to the growth cone along axons and in neurons. (PMID:20810886)
  • results suggest that Rab5 is involved in CB2 endocytosis and that internalized receptors are recycled via a Rab11 associated pathway rather than the rapid Rab4 associated pathway. (PMID:21640764)
  • Rab11 is differentially phosphorylated by distinct PKC isoenzymes; this post-translational modification might be a regulatory mechanism of intracellular trafficking. (PMID:22188018)
  • These findings suggest that Rab11-FIP1 proteins participate in spatially and temporally distinct steps of the recycling process along a complex and dynamic tubular network in which Rab11-FIPs occupy discrete domains (PMID:23283983)
  • findings support a model for HIV-1 Env incorporation in which specific targeting to the particle assembly microdomain on the plasma membrane is mediated by FIP1C and Rab14 (PMID:23592992)
  • rab11 effector protein FIP1 regulates adiponectin trafficking and secretion (PMID:24040321)
  • Mitochondrial remodeling was associated with increased proximity between Rab11a and mitochondrial membranes, changes in fusion-fission dynamics, and mitochondrial relocalization of the Drp1, which was regulated by the Rab11a effector protein FIP1/RCP. (PMID:24302731)
  • We find that Rab14 indeed binds to RCP, albeit with reduced affinity relative to conventional Rab11-FIP and Rab25-FIP complexes. However, in vivo, Rab11 recruits RCP onto biological membranes. (PMID:26032412)
  • GTPase Rab11, but not Rab4, is involved in the recycling of hERG channels. (PMID:26152716)
  • REI/SH3BP5 protein family is conserved in evolution and is a group of new guanine nucleotide exchange factors for Rab11. (PMID:26745340)
  • Rab11-FIP1A associates with and regulates trafficking at an early step in the process of membrane recycling (PMID:26790954)
  • our findings indicate that FIP1C acts as a tumor suppressor in the context of ErbB2-positive breast cancer (PMID:26933086)
  • Findings suggest that overexpression of micro ribonucleic acid-93 (miR-93) via targeting RAB11 family interacting protein (RAB11FIP1) as an early event plays an important role in oncogenesis of cervical cancer. MiR-93 and its target protein RAB11FIP1 may be potential therapeutic targets for cervical cancer and its precursors. (PMID:27279231)
  • High RCP expression is associated with lung metastasis in ovarian cancer. (PMID:27524413)
  • The article focuses on the latest advances regarding the mechanisms that ensure the compartmentalized regulation of Rab11 function through its interaction with phosphoinositides. (Review) (PMID:27658318)
  • Phosphorylation of RCP at Ser(435) by Lemur tyrosine kinase-3 (LMTK3) and of EphA2 at Ser(897) by Akt are both necessary to promote Rab14-dependent (and Rab11-independent) trafficking of EphA2 which generates cell:cell repulsion events that drive tumour cells apart. (PMID:28294115)
  • The findings thus define that delivery of recycling cargo toward the ERC requires spatial and sequential coupling of Rab11 activity with PtdIns(3)P turnover. (PMID:29915378)
  • Mutant p53 Drives Cancer Metastasis via RCP-Mediated Hsp90alpha Secretion. (PMID:32640214)
  • Zeb1 for RCP-induced oral cancer cell invasion and its suppression by resveratrol. (PMID:32728068)
  • Thrombin-activated PAR1 membrane expression is regulated by Rab11a-RCP complex dissociation. (PMID:32860953)
  • Rab11FIP1 maintains Rab35 at the intercellular bridge to promote actin removal and abscission. (PMID:34152390)
  • Rab11-FIP1 and Rab11-FIP5 Regulate pIgR/pIgA Transcytosis through TRIM21-Mediated Polyubiquitination. (PMID:34638806)
  • Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4[+] T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines. (PMID:36354340)
  • microRNA-205 represses breast cancer metastasis by perturbing the rab coupling protein [RCP]-mediated integrin beta1 recycling on the membrane. (PMID:37945815)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriorab11fip1aENSDARG00000046124
mus_musculusRab11fip1ENSMUSG00000031488
rattus_norvegicusRab11fip1ENSRNOG00000058940
drosophila_melanogasterRip11FBGN0027335
caenorhabditis_elegansWBGENE00021456

Paralogs (2): RAB11FIP2 (ENSG00000107560), RAB11FIP5 (ENSG00000135631)

Protein

Protein identifiers

Rab11 family-interacting protein 1Q6WKZ4 (reviewed: Q6WKZ4)

Alternative names: Rab-coupling protein

All UniProt accessions (2): Q6WKZ4, E7EX40

UniProt curated annotations — full annotation on UniProt →

Function. A Rab11 effector protein involved in the endosomal recycling process. Also involved in controlling membrane trafficking along the phagocytic pathway and in phagocytosis. Interaction with RAB14 may function in the process of neurite formation.

Subunit / interactions. Interacts with RAB11A (GTP-bound form); the interaction induces RAB11FIP1 recruitment to membranes. Interacts with RAB14 (GTP-bound form). Homooligomer. Isoform 2 interacts with RAB4A, RAB11A, RAB11B and RAB25. According to PubMed:15280022, RAB4A binding to RAB11FIP1 is of very low affinity in vitro and in vivo.

Subcellular location. Recycling endosome. Cytoplasmic vesicle Cytoplasmic vesicle. Phagosome membrane.

Tissue specificity. Isoform 2 is expressed in brain, heart, testis, lung, spleen, ovary and small intestine.

Domain organisation. The FIP-RBD is involved in the interaction with Rab proteins.

Isoforms (5)

UniProt IDNamesCanonical?
Q6WKZ4-41, Rab11-FIP 1Byes
Q6WKZ4-32, Rab11-FIP 1C
Q6WKZ4-13, Rab11-FIP 1A
Q6WKZ4-24, Rab11-FIP 1H, No Rab11-binding protein 2
Q6WKZ4-55

RefSeq proteins (2): NP_001002814, NP_079427 (=MANE)

Domains & families (InterPro)

IDNameType
IPR000008C2_domDomain
IPR019018Rab-bd_FIP-RBDDomain
IPR035892C2_domain_sfHomologous_superfamily
IPR037245FIP-RBD_C_sfHomologous_superfamily
IPR037789FIP_classIFamily

Pfam: PF00168, PF09457

UniProt features (67 total): modified residue 19, compositionally biased region 13, sequence conflict 9, region of interest 7, splice variant 7, sequence variant 4, mutagenesis site 3, domain 2, helix 2, chain 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
4D0GX-RAY DIFFRACTION2.5

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6WKZ4-F147.190.10

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (19): 184, 202, 206, 234, 300, 315, 339, 341, 343, 345, 356, 357, 382, 435, 477, 529, 545, 758, 1135

Mutagenesis-validated functional residues (3):

PositionPhenotype
1254does not abolish the interaction with rab11a, homooligomerization and subcellular location. reduces the interaction with
1255abolishes the interaction with rab11a, rab4a and rab14, homooligomerization and subcellular location.
1256does not abolish the interaction with rab11a, homooligomerization and subcellular location. reduces the interaction with

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 278 (showing top): GGGACCA_MIR133A_MIR133B, PEREZ_TP63_TARGETS, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_HORMONE_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, GOMF_GTPASE_BINDING, GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION, GOBP_CELL_CELL_SIGNALING, PATIL_LIVER_CANCER, GTGCCTT_MIR506, GOBP_REGULATION_OF_PROTEIN_SECRETION, GOBP_EXOCYTOSIS, OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, GOBP_NEGATIVE_REGULATION_OF_TRANSPORT

GO Biological Process (3): protein transport (GO:0015031), regulated exocytosis (GO:0045055), negative regulation of adiponectin secretion (GO:0070164)

GO Molecular Function (2): small GTPase binding (GO:0031267), protein binding (GO:0005515)

GO Cellular Component (7): cytosol (GO:0005829), phagocytic vesicle membrane (GO:0030670), recycling endosome (GO:0055037), cytoplasm (GO:0005737), endosome (GO:0005768), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
cytoplasm2
transport1
intracellular protein localization1
establishment of protein localization1
exocytosis1
negative regulation of hormone secretion1
negative regulation of protein secretion1
negative regulation of multicellular organismal process1
adiponectin secretion1
regulation of adiponectin secretion1
GTPase binding1
binding1
endocytic vesicle membrane1
phagocytic vesicle1
endosome1
intracellular anatomical structure1
endomembrane system1
cytoplasmic vesicle1
intracellular vesicle1

Protein interactions and networks

STRING

1823 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RAB11FIP1RAB11AP24410987
RAB11FIP1RAB25P57735974
RAB11FIP1RAB4AP20338952
RAB11FIP1RAB11FIP3O75154939
RAB11FIP1RAB11FIP4Q86YS3932
RAB11FIP1MYO5BQ9ULV0848
RAB11FIP1ARF5P26437735
RAB11FIP1RAB1AP11476633
RAB11FIP1PLPBPO94903613
RAB11FIP1ARF6P26438609
RAB11FIP1EXOC7Q9UPT5584
RAB11FIP1RAB14P35287565
RAB11FIP1LETM2Q2VYF4543
RAB11FIP1DDHD2O94830532
RAB11FIP1ERLIN2O94905518

IntAct

94 interactions, top by confidence:

ABTypeScore
IKBKGIKBKBpsi-mi:“MI:0914”(association)0.980
RAB11AEVI5psi-mi:“MI:0914”(association)0.800
YWHAHABLIM1psi-mi:“MI:0914”(association)0.800
YWHABPIK3C2Apsi-mi:“MI:0914”(association)0.800
RAB11FIP1YWHAHpsi-mi:“MI:0914”(association)0.740
KLC1KIF5Bpsi-mi:“MI:0914”(association)0.730
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
CTBP2ZNF217psi-mi:“MI:0914”(association)0.690
YWHAGBLTP3Bpsi-mi:“MI:0914”(association)0.640
YWHAGBLTP3Bpsi-mi:“MI:2364”(proximity)0.640
RAB11BSH3BP5psi-mi:“MI:0914”(association)0.640
MMABDBTpsi-mi:“MI:0914”(association)0.620
RAB11ACHMLpsi-mi:“MI:2364”(proximity)0.610
YWHAHPLEKHG3psi-mi:“MI:0914”(association)0.610
YWHABBLTP3Bpsi-mi:“MI:2364”(proximity)0.610
YWHABBLTP3Bpsi-mi:“MI:0914”(association)0.610
YWHAEPIK3C2Apsi-mi:“MI:0914”(association)0.570
YWHAHBLTP3Bpsi-mi:“MI:0914”(association)0.570
YWHAHBLTP3Bpsi-mi:“MI:2364”(proximity)0.570
BAIAP2WASLpsi-mi:“MI:0914”(association)0.550
RAB11ASH3BP5psi-mi:“MI:0914”(association)0.530
YWHABPLEKHG3psi-mi:“MI:0914”(association)0.480
RAB11FIP1PASKpsi-mi:“MI:0217”(phosphorylation reaction)0.440
RAB11ALANCL1psi-mi:“MI:2364”(proximity)0.420
SEC24BRAB11FIP1psi-mi:“MI:0915”(physical association)0.400
Rab11aEVI5psi-mi:“MI:0914”(association)0.350

BioGRID (195): RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), ASAP1 (Affinity Capture-Western), RAB11FIP1 (Proximity Label-MS), RAB11FIP1 (Proximity Label-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS), RAB11FIP1 (Affinity Capture-MS)

ESM2 similar proteins: A2A995, A2ALU4, A4IGN8, A6NMK8, D3ZUI5, E1C2Q8, F1QGH6, O54931, O75128, O75363, O75410, O95425, P24275, P24588, P51827, Q1LWM5, Q1RMS0, Q1W617, Q3UHI0, Q3UMF0, Q3ZB98, Q499V8, Q53SF7, Q5JR59, Q5NBX1, Q5VWT5, Q5ZJ26, Q62394, Q66KC9, Q673G8, Q69ZL1, Q6GQV1, Q6INC4, Q6QZN6, Q6WKZ4, Q6Y685, Q7TP36, Q7TS75, Q80YN3, Q8BI29

Diamond homologs: C9J798, G3XA57, O43374, O95294, P41823, Q3B7T9, Q6DN14, Q6PFQ7, Q6WKZ4, Q7L804, Q8R361, Q9BXF6, Q9D620, Q9SKA3, Q9ZVT9, Q4KUS2, Q62768, Q62769, Q62770, Q8K0T7, Q8NB66, Q9UPW8, Q9Z1N9, O35681, P41885

SIGNOR signaling

1 interactions.

AEffectBMechanism
MARK2“up-regulates quantity”RAB11FIP1phosphorylation

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 94 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Activation of BAD and translocation to mitochondria778.4×3e-10
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex769.2×5e-10
SARS-CoV-1 targets host intracellular signalling and regulatory pathways769.2×5e-10
Activation of BH3-only proteins751.1×4e-09
RHO GTPases activate PKNs732.7×1e-07
Intrinsic Pathway for Apoptosis730.1×2e-07
FOXO-mediated transcription524.7×4e-05
Translocation of SLC2A4 (GLUT4) to the plasma membrane818.2×5e-07

GO biological processes:

GO termPartnersFoldFDR
protein targeting522.1×1e-03
intracellular protein localization911.3×8e-05
protein autophosphorylation610.5×5e-03
positive regulation of ERK1 and ERK2 cascade77.2×7e-03
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction76.6×8e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

214 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance178
Likely benign16
Benign5

Top pathogenic / likely-pathogenic (0)

SpliceAI

1302 predictions. Top by Δscore:

VariantEffectΔscore
8:37862956:T:TAdonor_gain1.0000
8:37870415:CATA:Cdonor_loss1.0000
8:37870416:ATAC:Adonor_loss1.0000
8:37870418:A:Cdonor_loss1.0000
8:37870419:C:Gdonor_loss1.0000
8:37870529:C:CCacceptor_gain1.0000
8:37875318:CATGA:Cacceptor_gain1.0000
8:37875319:ATGA:Aacceptor_gain1.0000
8:37875320:TGA:Tacceptor_gain1.0000
8:37875323:C:CCacceptor_gain1.0000
8:37875324:T:Cacceptor_gain1.0000
8:37875325:T:Cacceptor_gain1.0000
8:37875325:T:TCacceptor_gain1.0000
8:37877104:CTCA:Cdonor_loss1.0000
8:37877105:TCA:Tdonor_loss1.0000
8:37877106:CACC:Cdonor_loss1.0000
8:37877107:A:ACdonor_gain1.0000
8:37877107:A:Tdonor_loss1.0000
8:37877107:AC:Adonor_gain1.0000
8:37877107:ACCAT:Adonor_gain1.0000
8:37877108:C:CAdonor_gain1.0000
8:37877108:CC:Cdonor_gain1.0000
8:37877108:CCAT:Cdonor_gain1.0000
8:37877108:CCATC:Cdonor_gain1.0000
8:37899066:CTCA:Cdonor_gain1.0000
8:37899069:A:ACdonor_gain1.0000
8:37899069:ACTG:Adonor_gain1.0000
8:37899070:C:CGdonor_gain1.0000
8:37899070:CTG:Cdonor_gain1.0000
8:37899070:CTGC:Cdonor_gain1.0000

AlphaMissense

8351 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:37862974:A:GL1258P1.000
8:37899244:C:AW66C1.000
8:37899244:C:GW66C1.000
8:37899246:A:GW66R1.000
8:37899246:A:TW66R1.000
8:37862971:A:GL1259P0.999
8:37862995:A:GL1251P0.999
8:37863058:A:GL1230P0.999
8:37877480:A:GF148S0.999
8:37877492:A:TV144D0.999
8:37877498:A:TI142N0.999
8:37877505:C:GG140R0.999
8:37877505:C:TG140R0.999
8:37877540:A:GL128S0.999
8:37899128:C:TG105D0.999
8:37899129:C:GG105R0.999
8:37899133:G:CF103L0.999
8:37899133:G:TF103L0.999
8:37899134:A:GF103S0.999
8:37899135:A:GF103L0.999
8:37899140:T:AD101V0.999
8:37899173:A:GL90P0.999
8:37899227:A:GF72S0.999
8:37899245:C:GW66S0.999
8:37899318:A:CY42D0.999
8:37862962:A:TV1262D0.998
8:37863049:A:GL1233P0.998
8:37877504:C:AG140V0.998
8:37877504:C:TG140E0.998
8:37877540:A:CL128W0.998

dbSNP variants (sampled 300 via entrez): RS1000112202 (8:37878097 G>A,C), RS1000196590 (8:37898883 G>A,C,T), RS1000295767 (8:37877904 G>A,C), RS1000472151 (8:37861422 A>G), RS1000572142 (8:37861156 G>A), RS1000646840 (8:37896585 T>C), RS1000651405 (8:37899658 G>A,T), RS1000761431 (8:37899563 A>C,G,T), RS1000872124 (8:37890706 C>T), RS1000892933 (8:37866110 C>A,G,T), RS1000932782 (8:37872512 C>T), RS1000998571 (8:37859673 G>A,C), RS1001198966 (8:37900637 C>T), RS1001347322 (8:37888693 G>C), RS1001454580 (8:37868859 C>T)

Disease associations

OMIM: gene MIM:608737 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST002115_11Axial length3.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005318axial length measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

71 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases abundance, increases expression4
Valproic Acidincreases expression, affects expression4
Estradioldecreases expression, increases expression3
Smokedecreases expression3
Tobacco Smoke Pollutionaffects expression, increases expression3
methylmercuric chlorideincreases expression2
bisphenol Aincreases reaction, decreases expression, affects binding2
trichostatin Aaffects expression, increases expression2
Calcitriolincreases expression, affects cotreatment2
Doxorubicindecreases expression, affects response to substance2
Phenylmercuric Acetateaffects cotreatment, increases expression2
aristolochic acid Iincreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
FR900359affects phosphorylation1
ethylbenzeneincreases methylation, affects cotreatment, decreases expression1
triphenyl phosphateaffects expression1
sodium arsenatedecreases expression1
decabromobiphenyl etherdecreases expression1
butyraldehydeincreases expression1
tetrabromobisphenol Adecreases expression1
potassium chromate(VI)decreases expression1
coumarindecreases phosphorylation1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic aciddecreases expression1
CGP 52608affects binding, increases reaction1
entinostatincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideincreases expression, affects cotreatment1
erucylphospho-N,N,N-trimethylpropylammoniumincreases expression1
nutlin 3increases secretion, affects cotreatment1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.